The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 28, 2023
Filed:
Oct. 21, 2019
Applicant:
Advanced Accelerator Applications Usa, Inc., New York, NY (US);
Inventors:
Theodosia Maina-Nock, Athens, GR;
Berthold Artur Nock, Athens, GR;
Marion de Jong Hendriks, Vlaardingen, NL;
Assignee:
Other;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/08 (2006.01); A61K 45/06 (2006.01); A61K 31/265 (2006.01); A61K 31/7056 (2006.01); A61K 31/7028 (2006.01);
U.S. Cl.
CPC ...
A61K 51/085 (2013.01); A61K 31/265 (2013.01); A61K 31/7028 (2013.01); A61K 31/7056 (2013.01); A61K 45/06 (2013.01); A61K 51/08 (2013.01); A61K 51/083 (2013.01); A61K 51/086 (2013.01); A61K 51/088 (2013.01);
Abstract
The present invention relates to a compound that inhibits the activity of a degrading enzyme for use in combination with a therapeutic or diagnostic compound, preferably a moiety conjugated peptide, in the diagnosis and/or treatment of a disease, in particular cancer, to enhance targeting of the therapeutic or diagnostic compound to the disease site.
Maina-Nock, Theodosia. (2023). Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors (U.S. Patent No. 11612667). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11612667
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile